CODX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Stats
Today's Volume	18 402.00
Average Volume	58 187.00
Market Cap	35.95M
EPS	$0 ( 2024-03-14 )
Next earnings date	( $-0.210 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.960
ATR14	$0.00800 (0.69%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Abbott Richard David	Buy	0	Common Stock
2024-03-15	Abbott Richard David	Buy	0	Common Stock
2024-03-15	Abbott Richard David	Buy	83 251	Common Stock Purchase Warrants
2024-03-15	Abbott Richard David	Sell	50 438	Restricted Stock Units
2023-11-23	Durenard Eugene	Sell	30 000	Restricted Stock Unit

INSIDER POWER
27.39
Last 96 transactions
Buy: 3 281 333 \| Sell: 1 334 875

Volume Correlation

Long: -0.12 (neutral)

Short: -0.35 (neutral)

Signal:(45.898) Neutral

Co-Diagnostics Inc Correlation

10 Most Positive Correlations
FLNT	0.981
FFWM	0.976
TOI	0.972
FSEA	0.969
MRBK	0.969
ESPR	0.963
CASA	0.963
PFSW	0.963
PTVE	0.963
PACW	0.962

10 Most Negative Correlations
SUMO	-0.974
DSPG	-0.96
DRNA	-0.952
STAY	-0.949
PPD	-0.94
MMAC	-0.938
SMED	-0.935
NVCN	-0.935
AMRB	-0.934
FTIV	-0.933

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Co-Diagnostics Inc Correlation - Currency/Commodity

-0.23
( neutral )

-0.44
( neutral )

0.00
( neutral )

-0.42
( neutral )

0.00
( neutral )

0.61
( weak )

Co-Diagnostics Inc Financials

Annual	2023
Revenue:	$991 473
Gross Profit:	$-4.42M (-446.20 %)
EPS:	$-1.200

Q4	2023
Revenue:	$3.56M
Gross Profit:	$274 458 (7.72 %)
EPS:	$-0.470

Q3	2023
Revenue:	$2.46M
Gross Profit:	$2.20M (89.59 %)
EPS:	$-0.200

Q2	2023
Revenue:	$197 806
Gross Profit:	$-261 289 (-132.09 %)
EPS:	$-0.310

Financial Reports:

No articles found.

Co-Diagnostics Inc

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.